Continuing education and learning

The Myeloma Academy is dedicated to supporting and educating healthcare professionals to ensure patients are diagnosed quicker, best practice is shared and patients receive the best possible treatment and care.   Aided by advances in technology, the myeloma field, particularly in the last decade, has rapidly evolved both scientifically and medically. This means that the…

Diagnostic tests and prognostic indicators

Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden. Giles SL et al. Clin Radiol. 2015 Mar 19. pii: S0009-9260(15)00074-4. doi: 10.1016/j.crad.2015.02.013. [Epub ahead of print]. The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs. Franssen LE et al. Bone Marrow Transplant. 2015 Mar 23. doi: 10.1038/bmt.2015.48.…

Related conditions

Translocation t(11;14) Is Associated With Adverse Outcome in Patients With Newly Diagnosed AL Amyloidosis When Treated With Bortezomib-Based Regimens. Bochtler T et al. J Clin Oncol. 2015 Mar 16. pii: JCO.2014.57.4947. [Epub ahead of print]. Extracorporeal Membrane Oxygenation as Bridge-to-Decision in Acute Heart Failure due to Systemic Light-Chain Amyloidosis. Mancio Silva J et al. Am J Case Rep. 2015 Mar 24;15:174-81.…